Changle Ji

726 total citations
19 papers, 460 citations indexed

About

Changle Ji is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Changle Ji has authored 19 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Changle Ji's work include Circular RNAs in diseases (9 papers), Cancer-related molecular mechanisms research (9 papers) and MicroRNA in disease regulation (9 papers). Changle Ji is often cited by papers focused on Circular RNAs in diseases (9 papers), Cancer-related molecular mechanisms research (9 papers) and MicroRNA in disease regulation (9 papers). Changle Ji collaborates with scholars based in China and Australia. Changle Ji's co-authors include Lin Fang, Xiaochong Deng, Xuehui Wang, Jiashu Hu, Kaiyao Hua, Yunhe Yu, Wenfang Zheng, Hongming Song, Yijun Deng and Tianqi Wu and has published in prestigious journals such as BioMed Research International, Cell Death and Disease and Frontiers in Pharmacology.

In The Last Decade

Changle Ji

19 papers receiving 455 citations

Peers

Changle Ji

ONCOL

PRM

Xiaochong Deng China

Yasu Jiang China

Lihua Ding China

Yin‐Ling Xiu China

Haitao Zhang China

Jiangzhou Ji China

Yang Shao China

Purificación Estévez-García Spain

Woo Chan Shin South Korea

Zhen‐Ming Xu China

Xiaochong Deng China

Changle Ji

341 ×0.9

225 ×0.8

54 ×0.9

ONCOL

83 ×1.6

26 ×0.7

PRM

Citations per year, relative to Changle Ji Changle Ji (= 1×) peers Xiaochong Deng

Countries citing papers authored by Changle Ji

Since Specialization

Citations

This map shows the geographic impact of Changle Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changle Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changle Ji more than expected).

Fields of papers citing papers by Changle Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changle Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changle Ji. The network helps show where Changle Ji may publish in the future.

Co-authorship network of co-authors of Changle Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Changle Ji. A scholar is included among the top collaborators of Changle Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changle Ji. Changle Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zheng, Wenfang, Xuehui Wang, Yunhe Yu, Changle Ji, & Lin Fang. (2023). CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop. Cellular & Molecular Biology Letters. 28(1). 34–34. 14 indexed citations

Yu, Yunhe, Wenfang Zheng, Changle Ji, et al.. (2022). Tumor-Derived circRNAs as Circulating Biomarkers for Breast Cancer. Frontiers in Pharmacology. 13. 811856–811856. 15 indexed citations

Ji, Changle, Linbo Zhu, & Lin Fang. (2022). Hsa_circ_0000851 promotes PDK1/p-AKT-mediated cell proliferation and migration by regulating miR-1183 in triple-negative breast cancer. Cellular Signalling. 101. 110494–110494. 8 indexed citations

Luo, Qifeng, Wenfang Zheng, Xiaochong Deng, et al.. (2022). Circular RNA_0006014 promotes breast cancer progression through sponging miR-885-3p to regulate NTRK2 and PIK3/AKT pathway. Aging. 14(7). 3105–3128. 18 indexed citations

Wang, Xuehui, Changle Ji, Jiashu Hu, et al.. (2021). Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 29–29. 57 indexed citations

Deng, Xiaochong, Changle Ji, Xuehui Wang, et al.. (2021). KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition. Gland Surgery. 10(6). 1941–1950. 27 indexed citations

Deng, Xiaochong, Kaiyao Hua, Hongming Song, et al.. (2021). MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor. Cell Death and Disease. 12(9). 810–810. 17 indexed citations

Huang, Yixiang, Wenfang Zheng, Changle Ji, et al.. (2021). Circular RNA circRPPH1 promotes breast cancer progression via circRPPH1-miR-512-5p-STAT1 axis. Cell Death Discovery. 7(1). 376–376. 22 indexed citations

Ji, Changle, Jiashu Hu, Xuehui Wang, et al.. (2021). Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis. Aging. 13(7). 9627–9645. 17 indexed citations

10.

Wang, Xuehui, Changle Ji, Wenfang Zheng, et al.. (2021). The Role of miR-640: A Potential Suppressor in Breast Cancer via Wnt7b/β-catenin Signaling Pathway. Frontiers in Oncology. 11. 13 indexed citations

11.

Chen, Lei, Xuehui Wang, Changle Ji, Jiashu Hu, & Lin Fang. (2020). MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis by targeting YAP1. Pathology - Research and Practice. 216(12). 153231–153231. 25 indexed citations

12.

Hua, Kaiyao, Xiaochong Deng, Jiashu Hu, et al.. (2020). Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 58–58. 42 indexed citations

13.

Wu, Tianqi, Hongming Song, Dan Xie, et al.. (2020). Mir‐30b‐5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2. BioMed Research International. 2020(1). 7907269–7907269. 17 indexed citations

14.

Hu, Jiashu, Changle Ji, Kaiyao Hua, et al.. (2020). Hsa_circ_0091074 regulates TAZ expression via microRNA‑1297 in triple negative breast cancer cells. International Journal of Oncology. 56(5). 1314–1326. 22 indexed citations

15.

Song, Hongming, Qifeng Luo, Xiaochong Deng, et al.. (2019). VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer. Experimental & Molecular Medicine. 51(11). 1–13. 35 indexed citations

16.

Xie, Dan, Hongming Song, Tianqi Wu, et al.. (2018). MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase�1 in breast cancer cells. Oncology Reports. 40(6). 3416–3426. 50 indexed citations

17.

Wu, Tianqi, Hongming Song, Dan Xie, et al.. (2018). Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway. International Journal of Oncology. 52(6). 2001–2010. 17 indexed citations

18.

Song, Hongming, Dengfeng Li, Tianqi Wu, et al.. (2018). MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD. BMB Reports. 51(11). 602–607. 40 indexed citations

19.

Sun, Jun, et al.. (2016). Can hemozoin alone cause host anaemia?. Parasitology Research. 115(12). 4611–4616. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact